Key facts
| Price (PPV) | 107.50 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | ramiprilhydrochlorothiazide |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09BA05 |
| Manufacturer | SANOFI AVENTIS MAROC |
| Presentation | Boîte de 28 |
| Nature | Médicament |
| Hospital price | 67.20 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de l'hypertension. Cette association à dose fixe est indiquée chez les patients dont la pression artérielle n'est pas adéquatement contrôlée par le ramipril seul ou l'hydrochlorothiazide seul.
Find an open pharmacy
On-call pharmacies near you
About Tritazide 5 mg / 25 mg
Tritazide 5 mg / 25 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by SANOFI AVENTIS MAROC and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Tritazide 5 mg / 25 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Tritazide 5 mg / 25 mg
Answers to common questions from Moroccan patients about this drug.